Loading
A phase 1/2 trial in triple-negative breast cancer, run by National University Hospital, Singapore, now recruiting.
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer is a phase 1/2, interventional study registered as NCT05491083 by National University Hospital, Singapore, with a registry enrolment figure of 51 participants, started 2023-06-12 and due to reach its primary completion in 2026-12-31. Interventions recorded: Pembrolizumab & ADG106 (Phase Ib); Pembrolizumab & ADG106 (Phase II). Conditions listed: Advanced Solid Tumor; Triple Negative Breast Cancer. Triple-negative eligibility wording from the registry: "* Patients with histologically or cytologically confirmed TNBC, defined by expression of estrogen (ER) and progesterone receptors (PR) of \<1% and HER2 IHC score of 0 or 1+ or HER2 IHC score of 2+ but HER2 FISH negative". Sites: Singapore. No results are recorded here; the registry entry is the source.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.